The Journal of Clinical Endocrinology & Metabolism · 2019 · 23 citations · 39 references
MedicineEndocrinologyPathologyEndocrine GeneticsNeoplasiaPediatric EndocrinologyInsulin ResistanceThyroid CancerThyroid DisordersThyroid EndocrinologyThyroid UltrasonographyThyroid UltrasoundPediatric Thyroid DiseasePediatric Thyroid DisordersPediatric Thyroid UltrasonographyPediatric Thyroid UltrasoundThyroid AnatomyThyroid EnlargementThyroid HyperplasiaThyroid Volume Assessment
CONTEXT: Insulin and leptin may increase growth and proliferation of thyroid cells, underlying an association between type 2 diabetes and papillary thyroid cancer (PTC). Patients with extreme insulin resistance due to lipodystrophy or insulin receptor mutations (INSR) are treated with high-dose insulin and recombinant leptin (metreleptin), which may increase the risk of thyroid neoplasia. OBJECTIVE: The aim of this study was to analyze thyroid structural abnormalities in patients with lipodystrophy and INSR mutations and to assess whether insulin, IGF-1, and metreleptin therapy contribute to the thyroid growth and neoplasia in this population. DESIGN: Thyroid ultrasound characteristics were analyzed in 81 patients with lipodystrophy and 11 with INSR (5 homozygous; 6 heterozygous). Sixty patients were taking metreleptin. RESULTS: The prevalence of thyroid nodules in children with extreme insulin resistance (5 of 30, 16.7%) was significantly higher than published prevalence for children (64 of 3202; 2%), with no difference between lipodystrophy and INSR. Body surface area-adjusted thyroid volume was larger in INSR homozygotes vs heterozygotes or lipodystrophy (10.4 ± 5.1, 3.9 ± 1.5, and 6.2 ± 3.4 cm2, respectively. Three patients with lipodystrophy and one INSR heterozygote had PTC. There were no differences in thyroid ultrasound features in patients treated vs not treated with metreleptin. CONCLUSION: Children with extreme insulin resistance had a high prevalence of thyroid nodules, which were not associated with metreleptin treatment. Patients with homozygous INSR mutation had thyromegaly, which may be a novel phenotypic feature of this disease. Further studies are needed to determine the etiology of thyroid abnormalities in patients with extreme insulin resistance.
39
Delafield Du Bois · Archives of internal medicine · 1916 · 4.3K citations
Medicine, Pediatrics, Physiology +15
Intracellular signalling pathways activated by leptin
Biochemical Journal · 2005 · 689 citations · Full text